These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 10871825)
1. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825 [TBL] [Abstract][Full Text] [Related]
2. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Sijens PE; Mostert JP; Oudkerk M; De Keyser J Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056 [TBL] [Abstract][Full Text] [Related]
3. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491 [TBL] [Abstract][Full Text] [Related]
4. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. Adalsteinsson E; Langer-Gould A; Homer RJ; Rao A; Sullivan EV; Lima CA; Pfefferbaum A; Atlas SW AJNR Am J Neuroradiol; 2003; 24(10):1941-5. PubMed ID: 14625214 [TBL] [Abstract][Full Text] [Related]
5. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study. Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201 [TBL] [Abstract][Full Text] [Related]
6. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis. Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072 [TBL] [Abstract][Full Text] [Related]
7. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260 [TBL] [Abstract][Full Text] [Related]
8. Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging. Sun J; Song H; Yang Y; Zhang K; Gao X; Li X; Ni L; Lin P; Niu C Medicine (Baltimore); 2017 Apr; 96(14):e6534. PubMed ID: 28383419 [TBL] [Abstract][Full Text] [Related]
9. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707 [TBL] [Abstract][Full Text] [Related]
10. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis]. Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432 [TBL] [Abstract][Full Text] [Related]
11. Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis. Khan O; Shen Y; Caon C; Bao F; Ching W; Reznar M; Buccheister A; Hu J; Latif Z; Tselis A; Lisak R Mult Scler; 2005 Dec; 11(6):646-51. PubMed ID: 16320723 [TBL] [Abstract][Full Text] [Related]
12. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; McLean MA; Miller DH; Thompson AJ Arch Neurol; 2005 Apr; 62(4):569-73. PubMed ID: 15824254 [TBL] [Abstract][Full Text] [Related]
13. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy. Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618 [TBL] [Abstract][Full Text] [Related]
15. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651 [TBL] [Abstract][Full Text] [Related]
16. 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. Leary SM; Davie CA; Parker GJ; Stevenson VL; Wang L; Barker GJ; Miller DH; Thompson AJ J Neurol; 1999 Nov; 246(11):1023-6. PubMed ID: 10631633 [TBL] [Abstract][Full Text] [Related]
17. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla. Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023 [TBL] [Abstract][Full Text] [Related]